Fuse is an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace. We provide a comprehensive portfolio of products in the orthopedic total joints, sports medicine, trauma, foot and ankle space, as well as, degenerative and deformity spine, osteobiologics, wound care, and regenerative products. For more information about the Company, or if you’re interested in becoming a distributor of any Fuse’s products, please contact us at info@fusemedical.com or visit: www.fusemedical.com.
Company profile
Ticker
FZMD
Exchange
Website
CEO
Christopher C. Reeg
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Former names
AMERICAN METALS SERVICE INC, GOLF ROUNDS COM INC
SEC CIK
Corporate docs
Subsidiaries
CPM Medical Consultants, LLC ...
IRS number
591224913
FZMD stock data
Latest filings (excl ownership)
8-K
Changes in Registrant's Certifying Accountant
22 Nov 22
8-K
Fuse Medical, Inc. Announces Third Quarter 2022 Financial Results
18 Nov 22
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
8-K
Submission of Matters to a Vote of Security Holders
27 Jun 22
10-Q
2022 Q1
Quarterly report
12 May 22
DEFA14A
Additional proxy soliciting materials
10 May 22
DEF 14A
Definitive proxy
10 May 22
8-K
Departure of Directors or Certain Officers
8 Apr 22
10-K
2021 FY
Annual report
31 Mar 22
Latest ownership filings
Financial summary
| Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Institutional ownership, Q3 2019
| 13F holders | Current |
|---|---|
| Total holders | 0 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 0.00 |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 15 Dec 22 | Brooks Mark W | Grant | Acquire A | No | No | 0.15 | 333,333 | 50.00 k | 882,586 | |
| 15 Dec 22 | Lawrence Scott Yellin | Grant | Acquire A | No | No | 0.15 | 333,333 | 50.00 k | 333,333 | |
| 15 Dec 22 | Reeg Christopher C | Grant | Acquire A | No | No | 0.15 | 333,333 | 50.00 k | 882,586 | |
| 16 Nov 22 | Brooks Mark W | Restricted Stock | Gift | Dispose G | Yes | No | 0 | 600,000 | 0.00 | 54,020,130 |